Dan Gillie
About Dan Gillie
Dan Gillie is a Senior Scientist II at Fulcrum Therapeutics, specializing in electrophysiology techniques to study neuro-degenerative and neuro-muscular diseases. He has extensive experience in the pharmaceutical industry and academia, with a focus on ion channels and drug discovery.
Current Role at Fulcrum Therapeutics
Dan Gillie serves as a Senior Scientist II at Fulcrum Therapeutics, a position he has held since 2018. In this role, he focuses on advancing research in the field of neurobiology and drug discovery. His work involves utilizing advanced electrophysiology techniques, including multi-electrode arrays, to explore neuro-degenerative and neuro-muscular diseases. His contributions aim to enhance the understanding of these conditions and support the development of innovative therapeutic strategies.
Previous Experience at GlaxoSmithKline
Prior to his current role, Dan Gillie worked at GlaxoSmithKline for a total of nine years, first as a Scientist from 2006 to 2009 and later as a Senior Scientist from 2009 to 2015. During his tenure in RTP, NC, he gained extensive experience in pharmacological modulation of ion channels and transporters. His work contributed to various drug discovery initiatives and provided him with a solid foundation in both the pharmaceutical industry and research.
Educational Background
Dan Gillie earned his Bachelor of Science (B.S.) in Biology/Biological Sciences from Houghton College, graduating with honors in 1998. He furthered his education at the University of North Carolina at Chapel Hill, where he studied Neurobiology and ion channels for one year. Although he did not complete a degree at UNC, this experience enhanced his understanding of complex biological systems, particularly in relation to nerve and muscle functions.
Research Expertise and Interests
Dan Gillie possesses expertise in the molecular, cellular, and electrophysiological mechanisms that underlie muscle, nerve, and epithelial function. His research interests include the pharmacological modulation of ion channels and transporters, as well as the development of bio-assays for drug discovery. Additionally, he is interested in alternative therapy modulation of diseases without medications and the impact of microbiome modulation on human physiology.
Professional Experience and Skills
With nearly two decades of experience in both academia and the pharmaceutical industry, Dan Gillie has developed a comprehensive skill set. His proficiency in advanced screening technologies and bio-assay development is complemented by his deep understanding of neurobiology. His work spans multiple disease areas and target classes, reflecting his versatility and commitment to advancing scientific knowledge in the field.